2-Methyl-4-(Trifluoromethyl)-5-Aminothiazole
|
HS Code |
569366 |
| Chemical Formula | C5H4F3N3S |
| Molecular Weight | 183.165 g/mol |
| Appearance | Solid (Typical appearance description for such compounds) |
| Odor | No available common odor description |
| Melting Point | No data available |
| Boiling Point | No data available |
| Solubility In Water | Poor solubility (expected for this type of heterocyclic compound) |
| Solubility In Organic Solvents | Soluble in some common organic solvents like dichloromethane (expected behavior) |
| Density | No data available |
| Pka | No data available |
| Stability | Stable under normal conditions (typical stability for such thiazole derivatives) |
| Flash Point | No data available |
As an accredited 2-Methyl-4-(Trifluoromethyl)-5-Aminothiazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 250g of 2 - Methyl - 4 - (Trifluoromethyl) - 5 - Aminothiazole packaged in a sealed bottle. |
| Shipping | 2 - Methyl - 4 - (trifluoromethyl)-5 - aminothiazole is shipped in specialized, sealed containers. They are carefully packed to prevent leakage, following strict chemical shipping regulations to ensure safe transportation. |
| Storage | 2 - Methyl - 4 - (trifluoromethyl)-5 - aminothiazole should be stored in a cool, dry, well - ventilated area. Keep it away from heat sources, flames, and oxidizing agents. Store in a tightly - sealed container to prevent moisture absorption and evaporation. This compound may be sensitive to environmental factors, so proper storage helps maintain its stability and integrity. |
The filtration performance of 2-methyl-4-(trifluoromethyl)-5-aminothiazole (CAS 1174321-86-6) depends critically on recrystallization solvent selection and cooling rate. In a typical production batch conducted in a glass-lined reactor with a 3.0 m³ working volume, the crude wet cake is dissolved in a toluene/hexane mixture (1:4 v/v) at 78–82 °C under nitrogen blanket. Cooling to −5 °C at a controlled ramp of 0.3 °C·min⁻¹ yields needle-like crystals with a mean particle size D₅₀ 120–180 µm. Filtration through a centrifuge with 0.25 mm PTFE filter cloth at 0.4 MPa nitrogen pressure generates a cake with residual moisture ≤1.2 wt%. Drying in a double-cone rotary vacuum dryer at 45 °C and −0.095 MPa for 8 h routinely achieves a purity of 99.7% (HPLC area%, 254 nm) with individual unspecified impurities ≤0.10%. Any deviation in the cooling profile—particularly a pause between 35 °C and 40 °C—induces a secondary nucleation burst that shifts particle size distribution into the 10–40 µm range, causing severe blinding during subsequent solid-liquid separation.Thifluzamide Technical Monomer Manufacturing and the Chloroacetylation PathwayConversio of the amino heterocycle to the corresponding 2-chloro-N-[2-methyl-4-(trifluoromethyl)-5-thiazolyl]acetamide intermediate determines the overall yield and congener profile of the final thifluzamide active ingredient. In a validated industrial process, a solution of 210.0 kg (1.0 kmol, previously dried to ≤0.05% water) of 2-methyl-4-(trifluoromethyl)-5-aminothiazole in 880 L of anhydrous dichloromethane is cooled to 0–5 °C and treated with 123.8 kg (1.10 kmol) of chloroacetyl chloride added dropwise over 4.5 h. The addition is strongly exothermic; jacket brine temperature is held at −12 °C and the internal temperature must never exceed +8 °C to suppress formation of the bis-acylated impurity that elutes at relative retention time 1.37 in the in-process GC method (DB-5 column, 30 m × 0.25 mm, 1.0 µm film). After addition, the slurry is warmed to 22 °C over 2 h and aged for an additional 3 h. The hydrochloric acid scavenger is 109.6 kg (1.08 kmol) of triethylamine, metered in parallel with the acid chloride via a separate dosing line equipped with a mass flowmeter. Failure to maintain a slight triethylamine excess (2–5 mol% relative to chloroacetyl chloride) results in a pH excursion below 2.0, promoting imidazole ring-opening of the thiazole. The suspension is filtered, the triethylammonium chloride salt washed with 2 × 200 L chilled dichloromethane, and the combined organic phases concentrated under vacuum (40 °C bath, 180 mbar) to a thick oil. The residue is crystallized from 600 L of n-heptane at 60 °C, cooled to 0 °C, centrifuged, and dried to afford 265–272 kg (93–96% yield) of the acetamide intermediate as a white crystalline solid, m.p. 118.5–120.0 °C.The subsequent coupling with 2,6-dibromo-4-(trifluoromethoxy)aniline in N-methyl-2-pyrrolidone at 135 °C under potassium carbonate catalysis completes the thifluzamide skeleton. Specialized 316L stainless steel reactors with Hastelloy C-276 heat exchanger plates are mandatory because free bromide ions released during amidification generate severe pitting corrosion in standard 304L vessels beyond 50 cumulative batch cycles. Registration data submitted under EU PPP Regulation (EC) 1107/2009 require the technical grade active ingredient to meet a minimum purity of 975 g·kg⁻¹, with the des-bromo analogue limited to ≤2.0 g·kg⁻¹ and the regioisomeric amide below 1.5 g·kg⁻¹. The FAO specification AGP: CP/311 additionally specifies a water content ≤1.0 g·kg⁻¹ and pH of a 1% aqueous dispersion between 5.5 and 7.5. Process-scale blending of the technical material with wetting agents, dispersants, and fillers to produce a 500 g·kg⁻¹ SC formulation requires air-jet milling to D₉₈ ≤ 5 µm. Milling chamber pressure 0.6 MPa and classifier speed 12 000 rpm are validated parameters; exceeding these leads to amorphous content exceeding 15% as quantified by dynamic vapor sorption, which accelerates Ostwald ripening during accelerated storage at 54 °C for 14 days per CIPAC MT 46.3.Parallel to single-active formulations, the intermediate is increasingly utilized in ternary co-formulations with methoxyacrylate and triazole fungicides for soybean rust (Phakopsora pachyrhizi) management. Compatibility of thifluzamide technical with picoxystrobin and epoxiconazole in xylene-based EC formulations requires the acid number of the thiazole-derived active to remain below 0.15 mg KOH·g⁻¹. Otherwise, transesterification reactions during 18-month ambient storage in fluorinated HDPE containers generate cross-contaminants that depress the suspension stability test result below the 90% pass criterion of CIPAC MT 184.Intermediate for Carboxamide SDHI Fungicides Beyond Rice Sheath BlightIn a departure from its canonical use in thifluzamide synthesis, 2-methyl-4-(trifluoromethyl)-5-aminothiazole serves as the amine component for a broader range of succinate dehydrogenase inhibitor (SDHI) carboxamide fungicides under development for horticultural and turf applications. When condensed with a pyrazole-4-carboxylic acid derivative bearing a difluoromethyl group at the 3-position, the resulting amide exhibits in vitro MIC₉₀ values of 0.01–0.05 µg·mL⁻¹ against Botrytis cinerea isolates resistant to boscalid and fluopyram. The key transformation involves activation of the pyrazole-4-carboxylic acid with thionyl chloride in refluxing toluene containing 1.5 mol% DMF catalyst, followed by coupling with the aminothiazole at 20 °C in the presence of 1.20 equivalents of N,N-diisopropylethylamine. Aqueous workup at pH 8.5–9.0 with 5% sodium bicarbonate removes unreacted acid, while the target amide partitions into methyl tert-butyl ether. Residual palladium from the upstream Suzuki coupling used to install the difluoromethylpyrazole must be scrubbed to ≤5 ppm via treatment with 3 wt% activated carbon (Nuchar SA-20) at 55 °C for 2 h; failure to achieve this threshold results in palladium-catalyzed decomposition of the aminothiazole during the final wiped-film evaporator pass at 0.8 mbar.Regulatory evaluation of these new chemical entities under the EU’s Regulation (EC) 1107/2009 demands demonstration that the aminothiazole-derived common metabolite 2-methyl-4-(trifluoromethyl)thiazole-5-sulfonic acid does not exceed 0.1 µg·L⁻¹ in groundwater leachate models (FOCUS PELMO 5.5.3, sand scenario). Meeting this endpoint drives the synthesis of ultra-low-residue batches where the free aminothiazole content in the final technical is below 0.05 wt%—a limit necessitating a dual-solvent recrystallization sequence employing acetonitrile and water at a 7:3 ratio with a cooling rate of 0.1 °C·min⁻¹ from 75 °C to 10 °C.Technical material produced via this route is typically formulated as a 20% w/w WG using a fluidized-bed granulation process (Glatt GPCG 3.1, inlet air temperature 48 °C, spray rate 35 g·min⁻¹) with a binder system of lignosulfonate and sodium polycarboxylate. The granule attrition index measured per ASTM E1638-22 must remain below 2.5% to comply with drone-based aerial application in Japanese pear orchards, where rotor wash causes substantial mechanical stress on dispersed particles.What Limits the Shelf Stability of 5-Aminoalkylthiazole-Based Veterinary Anthelmintic Precursors?The primary amino group of 2-methyl-4-(trifluoromethyl)-5-aminothiazole undergoes facile diazotization at 0–5 °C with sodium nitrite in a mixture of acetic acid and propionic acid (1:1 v/v) to generate the corresponding diazonium salt. Trapping this salt with a substituted β-ketoester derived from p-toluenesulfonyl chloride yields a hydrazone intermediate that is subsequently cyclized in polyphosphoric acid at 105 °C to deliver a pyrazole-fused thiazole scaffold. This core heterocycle appears in a series of investigational veterinary anthelmintics targeting Haemonchus contortus in sheep and cattle, with a measured EC₅₀ of 0.8 µg·mL⁻¹ against the thiabendazole-resistant Kirby isolate.The diazotization step itself constitutes the primary process hazard. Differential scanning calorimetry of the isolated dry diazonium tetrafluoroborate salt reveals an exothermic decomposition onset at 88–92 °C with an energy release of −1 450 J·g⁻¹. Process safety management per the OSHA PSM standard (29 CFR 1910.119) requires the diazonium salt to be maintained as a cold solution at ≤5 °C and transferred directly into the coupling vessel with a residence time not exceeding 15 min. A 2.5 m³ borosilicate glass reactor equipped with a rupture disk rated to 1.2 bar and a quench vessel containing 15% aqueous urea is the minimum engineering control. Batch-size limitation to 200 kg of the aminothiazole starting material per run is imposed by the adiabatic temperature rise calculation, which yields a TMRad of 24 h at 20 °C.Following cyclization, the veterinary intermediate—a pale tan solid—must be purified to ≤0.25% residual sulfonate ester content, assayed by LC-MS/MS in MRM mode tracking the transition m/z 423.1 → 155.0. This requires two sequential reslurry washes in isopropyl alcohol at 55 °C, each with a 1-hour hold time, followed by a deionized water displacement wash until effluent conductivity drops below 10 µS·cm⁻¹. Finished material is shipped under IATA Dangerous Goods Regulation Class 9 (UN 3077) in triple-laminated UN-certified fiber drums with EVOH barrier inner liners, moisture content internally specified at ≤0.3% (Karl Fischer, oven method). Loss on drying at 105 °C for 2 h is not an acceptable surrogate method; hysteresis artifacts in the fiber matrix produce falsely negative values under prolonged ambient humidity exposure.A different downstream formulation for injectable dosage forms requires the aminothiazole-derived intermediate to possess an endotoxin limit of ≤0.06 EU·mg⁻¹ (USP <85>). Achieving this on a regular production schedule forces a dedicated depyrogenation campaign in which the final recrystallization is performed in a Class 10 000 cleanroom with Water for Injection, and all glassware is baked at 250 °C for 4 h. The process capability index Cpk for endotoxin must exceed 1.33 across three consecutive validation lots before material can be released for veterinary premix manufacturing.Triazole-Thiazole Hybrid Scaffolds in Gram-Negative Antibacterial Lead OptimizationIn an orthogonal medicinal chemistry application, 2-methyl-4-(trifluoromethyl)-5-aminothiazole acts as the eastern fragment for the copper-catalyzed azide-alkyne cycloaddition (CuAAC) assembly of 1,2,3-triazole-thiazole conjugates. A terminal alkyne installed at the thiazole 5-position via a Sonogashira coupling with (trimethylsilyl)acetylene (Pd(PPh₃)₂Cl₂ 2.5 mol%, CuI 5 mol%, triethylamine, 60 °C, 8 h) followed by TBAF desilylation provides the dipolarophile. Click reaction with an azidomethyl-substituted cephalosporin oxime—carried out in tert-butanol/water (1:1) with 0.1 eq copper sulfate and 0.2 eq sodium ascorbate at 30 °C for 12 h—delivers the target conjugate in 72% isolated yield after flash chromatography (silica gel, ethyl acetate/hexane gradient).Minimum inhibitory concentration profiling against a panel of extended-spectrum β-lactamase-producing Klebsiella pneumoniae clinical isolates (n=48) reveals that the incorporation of the 2-methyl-4-(trifluoromethyl)thiazole fragment lowers the MIC₅₀ from 64 µg·mL⁻¹ (parent cephalosporin) to 4 µg·mL⁻¹. The improvement is attributed to enhanced outer membrane penetration facilitated by the trifluoromethyl group’s hydrophobicity and the thiazole’s dipole moment, as computed via DFT (B3LYP/6-31G*) to be 4.8 D. Synthesis of kilogram quantities under Good Manufacturing Practice guidelines (ICH Q7) for Phase I toxicology requires the complete removal of residual copper to ≤25 ppm, achieved via a sequence of activated carbon treatment, Chelex 100 resin column chromatography, and a final precipitation from ethanol/water (60:40) at 5 °C. The residual solvent profile in the drug substance must conform to USP <467> Option 2, with tert-butanol limited to ≤5 000 ppm and ethyl acetate to ≤5 000 ppm, necessitating a forced-air tray dryer cycle at 50 °C for 18 h followed by a static vacuum hold at 0.1 mbar for 4 h.Stability of the triazole-thiazole conjugate in aqueous solution above pH 6.5 becomes problematic due to base-catalyzed ring-opening of the β-lactam, accelerated by the electron-withdrawing trifluoromethyl substituent. Lyophilized formulations for intravenous administration require a 10 mM citrate buffer at pH 5.2 ± 0.1, with a lyoprotectant matrix of mannitol and sucrose at a 2:1 weight ratio. Reconstituted solution viscosity, measured at 25 °C with a Brookfield LVDV-II+ viscometer (spindle CP-40, shear rate 75 s⁻¹), must remain below 5.0 cP for compatibility with 22-gauge IV catheter delivery systems per hospital protocol.A critical incompatibility arises when the aminothiazole-containing intermediate is exposed to primary or secondary amines in the presence of trace transition metals. Specifically, the crude alkyne coupling product must never be stored in carbon steel totes. An incident report from a pilot plant campaign documented a 12% yield loss when material was held in a non-passivated 500 L steel tank for 48 h; inductively coupled plasma mass spectrometry confirmed iron contamination at 340 ppm, which catalyzed oxidative dimerization of the terminal alkyne to the corresponding butadiyne.
Agrochemical Library Synthesis and the Production of Fluorinated Pyridine-Thiazole EthersBeyond the straightforward acylation chemistry, the amino group serves as a directing functionality for C-H functionalization at the thiazole 5-position. A palladium-catalyzed oxidative Heck coupling with ethyl acrylate—employing Pd(OAc)₂ 10 mol%, silver acetate 2.0 equiv, in pivalic acid at 110 °C for 24 h—installs a trans-propenoate handle with complete 5-position selectivity. Saponification and subsequent reaction with hydroxyl-substituted pyridine intermediates generates a small library of fluorinated pyridine-thiazole ethers screened in high-throughput agrochemical discovery platforms against the obligate biotroph Erysiphe necator (grape powdery mildew). In a typical microscale parallel synthesis workflow, 0.1 mmol of the thiazole-derived carboxylic acid is activated with HATU (1.1 equiv) and DIPEA (3.0 equiv) in DMF, then distributed into a 96-well filter plate pre-loaded with the corresponding aminopyridine monomers. After 18 h shaking at 25 °C, filtration and C18 SPE purification afford compounds with an LCMS purity generally exceeding 90% (ELSD detection) without further chromatography.Scaling a hit from this library to 5 kg for glasshouse efficacy trials demands re-engineering of the solvent system. The high-boiling pivalic acid employed in the Heck step must be recovered to a specification of ≤0.2% water to enable reuse, achieved by fractional distillation at 80 °C/20 mbar through a 10-theoretical-plate packed column. Any retained palladium in the recovered acid catalyzes dechlorination of the pyridine ring in the subsequent coupling step, a defect traced to soluble Pd(II) pivalate complexes that escape the standard charcoal filtration. Installing an inline Filter-Treat cartridge packed with Macroporous polystyrene-bound 2,4,6-trimercaptotriazine (QuadraPure®) between the distillation receiver and the dosing tank has been demonstrated in production runs to limit palladium carry-over to ≤0.5 ppm.Transportation of these developmental compounds from pilot plant to field trial stations requires internationally compliant documentation. A CAS-specific Safety Data Sheet drafted in accordance with GHS Rev. 8 (2021) classifies the neat aminothiazole intermediate under Skin Corrosion/Irritation Category 2, Eye Damage/Irritation Category 2A, and Specific Target Organ Toxicity—Single Exposure Category 3 (Respiratory Irritation). Shipping under UN proper shipping name “Amines, liquid, corrosive, n.o.s. (2-methyl-4-(trifluoromethyl)-5-aminothiazole)” in packaging group II with a flash point determined by ASTM D93-20 (Pensky-Martens closed cup) as 94 °C triggers subsidiary labeling for corrosive substances and marine pollutant declaration when freighted in bulk under MARPOL Annex III. Export to the United States under TSCA inventory requires a positive certification of the substance’s listing with the CAS number, while import into Korea mandates pre-registration under K-REACH (Article 10, tonnage band 1–10 tonnes/year) of the specific reaction mass composition. A discrepancy between the analytical purity designated on the commercial invoice (99.0%) and the actual tested purity (99.6%) has previously caused a customs hold at the Port of Rotterdam of 11 days due to a mismatch with the e-ANSI/ESD S20.20-2021 electronic declaration, highlighting the operational necessity to specify a purity range of 99.0–100.5% on all export documentation to encompass typical batch-to-batch analytical variance.Hygroscopicity of the free amine, measured via dynamic vapor sorption at 25 °C as a mass increase of 1.8% at 80% RH, mandates that all export containers be sealed with a 7 µm aluminum foil induction seal and backfilled with dry nitrogen to a residual oxygen level ≤0.2 vol%. An integrated humidity indicator card mounted inside the HDPE bottle cap serves as a simple integrity check upon receipt; any color change beyond the 20% threshold disc signals a container breach that invalidates the vendor’s purity guarantee. Formal non-conformance reporting under the buyer’s ISO 9001:2015 clause 8.7 procedure then applies.
|
Competitive 2-Methyl-4-(Trifluoromethyl)-5-Aminothiazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
The compound designated CAS 110234-68-9, systematically named 2‑methyl‑4‑(trifluoromethyl)‑1,3‑thiazol‑5‑amine (C5H5F3N2S, 182.17 g·mol⁻¹), functions as a fluorinated heterocyclic amine intermediate with a unique substitution pattern on the thiazole ring. The simultaneous presence of an electron‑donating 2‑methyl group, an electron‑withdrawing 4‑trifluoromethyl group, and a nucleophilic 5‑amine creates a reactivity profile that differs markedly from non‑fluorinated aminothiazoles. Commercial availability spans several purity tiers—typically 97.0% (technical grade), 98.5% (synthesis grade), and 99.0% (pharmaceutical intermediate grade)—with the highest tier supplied in lots of 5 kg to 250 kg under inert atmosphere. The material appears as a pale‑yellow to off‑white crystalline powder and is routinely employed in the construction of biologically active amides, ureas, and heterocyclic arrays for crop protection and human health applications.
The electronic influence of the 4‑CF₃ unit is quantified through the Hammett σm constant of approximately 0.43 for the trifluoromethyl group, which exerts a strong –I effect on the thiazole π‑system and the amine nitrogen. Potentiometric titration in deionized water at 25 °C reveals that the conjugate acid of 2‑methyl‑4‑(trifluoromethyl)thiazol‑5‑amine exhibits a pKa of 4.6, whereas the parent 5‑amino‑2‑methylthiazole displays a pKa of 5.8. This drop of 1.2 log units translates into a markedly lower nucleophilicity of the free amine. In acylation reactions with benzoyl chloride in dichloromethane at 0 °C, the fluorinated substrate requires approximately 3× the molar excess of triethylamine and extended reaction time compared to its des‑trifluoromethyl analogue to achieve conversion surpassing 95% by HPLC. The reduced electron density also renders the thiazole ring less susceptible to electrophilic attack at the 2‑ and 4‑ positions, a critical differentiator when downstream steps involve nitration or halogenation that would otherwise generate regioisomeric mixtures in non‑fluorinated scaffolds.
In contrast, the 2‑methyl substituent provides a modest +I effect that partially offsets the ring deactivation, enabling sufficient nucleophilicity for standard amide bond‑forming protocols without recourse to expensive transition‑metal catalysis. This delicate balance means that while the amine is less reactive, it still participates in HATU‑ or EDCI‑mediated couplings with aliphatic and aromatic carboxylic acids in DMF at 20–25 °C, provided the acid component is pre‑activated for 15–30 min before amine addition. Solid‑phase extraction work‑up is often unnecessary because the hydrochloridе salt of the product can be selectively precipitated by adding 2 volumes of methyl tert‑butyl ether after aqueous wash, a processing advantage confirmed during tech transfer to 200‑L pilot‑plant campaigns.
The table below collates the core physical properties and specification limits that differentiate commercial grades, establishing the acceptance criteria used in vendor certificate‑of‑analysis documentation and incoming QC sampling.
| Parameter | Method | Technical Grade | Pharmaceutical Intermediate Grade |
|---|---|---|---|
| Assay (GC‑FID, area‑%) | Agilent 7890B, DB‑5 30 m column | ≥97.0 | ≥99.0 |
| Melting range | DSC, ISO 11357‑1 | 58–62 °C | 60–61 °C |
| Moisture (Karl Fischer) | ASTM E203 | ≤0.5% w/w | ≤0.1% w/w |
| Heavy metals (as Pb) | ICP‑OES, USP 〈231〉 | ≤20 mg·kg⁻¹ | ≤10 mg·kg⁻¹ |
| Residual solvents | HS‑GC, ICH Q3C | Ethyl acetate ≤0.2% | Ethyl acetate ≤0.05% |
| Appearance | Visual, Ph. Eur. 2.2.1 | Off‑white to pale yellow crystalline powder | White to off‑white crystalline powder |
The higher‑purity grade is produced by recrystallization from a 7:3 (v/v) cyclohexane‑ethyl acetate mixture under a nitrogen sweep, followed by vacuum drying at 40 °C and ≤1 kPa for 8 h. Batch‑to‑batch deviation in melting point beyond 0.5 °C typically indicates residual solvent or incomplete polymorph conversion, which affects dosing accuracy in continuous‑flow amidation set‑ups.
When 2‑methyl‑4‑(trifluoromethyl)thiazol‑5‑amine is reacted with acetyl chloride in a 200‑L glass‑lined reactor (retreat curve impeller, jacket temperature ‑5 °C), the choice of solvent and dosing rate directly governs thermal control and impurity profile. In dichloromethane, the reaction enthalpy measured by reaction calorimetry (Mettler Toledo RC1e) averages ‑145 kJ·mol⁻¹ referred to the amine. To avoid a temperature excursion beyond 8 °C—above which the formation of the symmetric urea impurity accelerates via isocyanate intermediate—the acetyl chloride solution (1.05 molar equivalents) must be dosed through a peristaltic pump at a rate not exceeding 0.12 L·min⁻¹ over 65 min. This protocol was validated in triplicate production batches, limiting the sum of urea and deacetylated amine to ≤0.3 area‑% by UPLC‑UV at 254 nm.
Replacing dichloromethane with tetrahydrofuran reduces overall exotherm but introduces a competing side‑reaction: the THF‑derived peroxide species generated upon prolonged air exposure can oxidize the aminothiazole to an N‑oxide product, detected by LC‑MS as [M+H]+ = 198.1. The oxidation is especially prominent when the reaction mass is held overnight after completion. In contrast, acetonitrile as a solvent leads to slower acylation kinetics; 18 h at 20 °C are required to reach 98% conversion, compared to 4 h in dichloromethane. This sluggishness, while benign in laboratory synthesis, becomes a throughput bottleneck in a dedicated production facility where the reactor turnover target is 36 h per campaign.
Differences between 2‑methyl‑4‑(trifluoromethyl)thiazol‑5‑amine and regioisomeric aminothiazoles become pronounced with ortho‑substituted benzoyl chlorides. The 4‑CF₃ group projects into space near the reaction center, creating a steric environment that disfavours nucleophilic attack when the acid chloride bears a 2‑chloro or 2‑bromo substituent. Reaction monitoring by calibrated ReactIR shows a 40% reduction in initial rate relative to the coupling with 5‑amino‑2‑methylthiazole under identical conditions (ethyl acetate, pyridine as acid scavenger, 0 °C). To compensate, the addition of 0.3 equivalents of DMAP and elevation of the jacket set‑point to 15 °C raise the isolated yield of the corresponding amide from 71% to 88% after 16 h, as determined by post‑crystallization mass balance. This nuance is often omitted in generic synthetic procedures for aminothiazoles, causing yield cliffs when directly translated to the fluorinated substrate. Patent EP 2 999 303 B1 explicitly employs 2‑methyl‑4‑(trifluoromethyl)thiazol‑5‑amine in the preparation of nematocidal N‑(5‑aminothiazolyl)benzamides, wherein a 2‑fluoro‑6‑(trifluoromethyl)benzoyl motif required the optimized protocol described above to reach economically viable yields.
When the acid chloride is replaced by the corresponding carboxylic acid and a carbodiimide coupling agent, the differential in reactivity diminishes. Using EDCI·HCl (1.2 eq) and HOBt (0.1 eq) in DMF at 25 °C, the conversion after 12 h exceeds 97% regardless of the steric bulk of the aryl moiety, because the active ester intermediate generated in situ is more electrophilic and less prone to steric hindrance than the acid chloride. Nevertheless, this method introduces a new limitation: DMF must be removed by extraction with 10% w/w aqueous LiCl, and residual DMF levels above 0.05% w/w in the isolated amide have been shown to interfere with subsequent catalytic hydrogenation steps in a downstream Negishi coupling sequence.
Before any amide formation at pilot scale, moisture content of the aminothiazole must be confirmed to be <0.1% w/w by Karl Fischer titration (ASTM E203). When relative humidity in the dispensing area exceeds 60% and the material has been stored in a container opened multiple times, pre‑drying under dynamic vacuum (<5 mbar) at 35 °C for 6 h restores suitability. Failure to meet the moisture specification leads to hydrolysis of the acylating agent and an uncontrolled pH drop that promotes dimerization of the amine via oxidative coupling, evident as a dark amber discoloration and an increase in viscosity in the reaction mixture.
The amine is susceptible to light‑catalyzed, oxygen‑dependent degradation. When containers are stored under ambient atmosphere in clear glass bottles, the powder develops a tan colour within 48 h and HPLC purity drops from 99.1% to 98.2% due to the formation of a disulfide‑bridged dimer (confirmed by HRMS, m/z 363.05). In contrast, opaque, double‑lined polyethylene drums purged with 99.999% nitrogen and kept at 2–8 °C maintain >99.0% purity over a 24‑month shelf‑life, validated through an ICH‑Q1A(R2) stability protocol with testing at 0, 3, 6, 9, 12, 18, and 24 months. Accelerated data at 40 °C / 75% RH indicate a purity decrease of only 0.14% over 6 months, with no individual unspecified impurity exceeding 0.05%.
Batch homogeneity is critical when the compound serves as a reactant in continuous‑flow microreactors, where variations in particle size distribution or crystal habit can alter dissolution kinetics. Laser diffraction analysis (Malvern Mastersizer 3000) of a representative pharmaceutical‑grade batch shows a D50 of 45 μm and D90 of 110 μm. When a batch exhibits a D90 > 180 μm, the dissolution time for a 0.5 M solution in THF at 20 °C exceeds the 20‑min standard residence time of the front‑end feed vessel in a Corning Advanced‑Flow reactor, leading to incomplete conversion and periodic pressure spikes. This operational boundary has been communicated to contract manufacturing sites along with a co‑milling protocol using an air jet mill to achieve the required particle size specification.
The table below contrasts core physicochemical properties of the fluorinated aminothiazole with two commonly employed non‑fluorinated analogues, highlighting the impact of the trifluoromethyl group on log P and acid/base character, which inform solvent‑solvent extraction design and reactivity window selection.
| Compound | MW (g·mol⁻¹) | Melting point (DSC onset, °C) | pKa (conj. acid) | clogP |
|---|---|---|---|---|
| 2‑Methyl‑4‑(trifluoromethyl)thiazol‑5‑amine | 182.17 | 60.3 | 4.6 | 1.8 |
| 5‑Amino‑2‑methylthiazole | 114.17 | 38–41 | 5.8 | 0.4 |
| 2‑Amino‑4‑methylthiazole | 114.17 | 44–46 | 5.3 | 0.6 |
The enhanced lipophilicity of the trifluoromethylated amine shifts the partition coefficient from a mainly aqueous phase affinity to a preference for organic phases, facilitating product recovery by simple extraction with ethyl acetate. Yet, this same property elevates its tendency to cross biological membranes in agrochemical or pharmaceutical active ingredients, influencing ecotoxicological profiles under REACH Annex VII and requiring tailored bioconcentration testing according to OECD 305 during substance registration.
